HCC - HEPATOCELLULAR CARCINOMA
Clinical trials for HCC - HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HCC - HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for HCC - HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Triple-Drug attack on advanced liver cancer shows promise
Disease control CompletedThis study tested whether adding a third drug (ipilimumab) to a standard two-drug combination (atezolizumab and bevacizumab) works better for people with advanced liver cancer that cannot be treated with surgery. It involved 229 patients who received either the two-drug or three-…
Matched conditions: HCC - HEPATOCELLULAR CARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: Federation Francophone de Cancerologie Digestive • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New hope for liver cancer patients when standard treatments fail
Disease control CompletedThis study looked at whether adding the drug lenalidomide could help control advanced liver cancer in patients whose cancer had continued to grow despite receiving standard treatments. Researchers observed 24 patients who had previously received lenvatinib and PD-1 inhibitor ther…
Matched conditions: HCC - HEPATOCELLULAR CARCINOMA
Phase: NA • Sponsor: Beijing Tsinghua Chang Gung Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New combo therapy fights tough liver cancer
Disease control CompletedThis study compared two treatment approaches for advanced liver cancer that had spread into a major vein. Researchers tested whether adding a targeted liver chemotherapy (HAIC) to standard drug therapy (lenvatinib and PD-1 inhibitors) worked better than the standard drugs alone. …
Matched conditions: HCC - HEPATOCELLULAR CARCINOMA
Sponsor: First Hospital of China Medical University • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC